New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Thursday, November 20, 2014 In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system. read more

View original post here:
New Findings Clarify How Immunotherapy Works — and Why, In Some People, It Doesn’t

Share

Immunotherapy Shows Promise for Treating Solid Tumors in the Chest

Add a Comment By Julie Grisham, MS, Science Writer/Editor   |  Wednesday, November 19, 2014 A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs. read more

Taken from:
Immunotherapy Shows Promise for Treating Solid Tumors in the Chest

Share

Three Johns Hopkins hospitals recognized as Top Performer on Key Quality Measures

Three Johns Hopkins Medicine hospitals are recipients of The Joint Commission’s 2013 Top Performer on Key Quality Measures award. The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions, including heart attack, heart failure, pneumonia, surgical care, children’s asthma, stroke, venous thromboembolism (VTE) and perinatal care, as well as for inpatient psychiatric services and immunizations.

More:
Three Johns Hopkins hospitals recognized as Top Performer on Key Quality Measures

Share